COMMUNIQUÉS West-GlobeNewswire

-
Acarix CADScor®System for early rule-out of Coronary Artery Disease (CAD) gains traction from established German users.
20/09/2018 -
Avid Bioservices to Exhibit at the 17th Annual Contracting & Outsourcing Conference
20/09/2018 -
Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences
20/09/2018 -
Selecta Biosciences to Present at the Jefferies Gene Therapy Summit on September 27, 2018
20/09/2018 -
Iterum Therapeutics to Present Clinical Data on Antibiotic Sulopenem at IDWeek 2018
20/09/2018 -
Wave Life Sciences to Present New Data on Its DMD Exon 53 Skipping Program and Discovery Platform at Upcoming Meetings
20/09/2018 -
OncoMed Provides Update on Navicixizumab Partnership
20/09/2018 -
Tetra Bio-Pharma Announces Significant Progress on Storz & Bickel Co-Development in Treating Fibromyalgia
20/09/2018 -
XBiotech Announces Addition of Top Dermatologist and Researcher Dr. Alice Gottlieb to its Team
20/09/2018 -
Galectin Therapeutics, Inc. Announces Positive Preliminary Results from Phase 1b Clinical Trial of GR-MD-02 and KEYTRUDA® in Advanced Melanoma and Expansion of the Trial
20/09/2018 -
Maverick Technology Solutions Receives Approval for Name Change and Symbol Change
20/09/2018 -
Cocrystal Pharma Completes Patient Enrollment in Phase 2a Study Evaluating CC-31244 for Ultra-Short Treatment of Hepatitis C
20/09/2018 -
Tabula Rasa HealthCare Brings Together PACE Medical Directors at 2018 Clinical Advisory Panel Meeting
20/09/2018 -
Avalon GloboCare Commences Operation of its Core GMP Platform, Epicon Biotech, to Facilitate Clinical Development of Cellular Therapies
20/09/2018 -
Precipio Expands ICE-COLD PCR™ Lung Cancer Mutation Detection Offering
20/09/2018 -
Integrated Cannabis Company, Inc. Signs Distribution Agreement with Empower Clinics, Inc.
20/09/2018 -
Conatus Pharmaceuticals to Host Analyst and Investor Symposium on Portal Hypertension
20/09/2018 -
FDA Accepts Asterias Biotherapeutics’ Request to Meet and Discuss Next Phase of Development for OPC1 Spinal Cord Injury Clinical Program
20/09/2018 -
Axovant to Present at Two Upcoming Investor Conferences
20/09/2018
Pages